Ocular Implants Market by Product (Intraocular Lenses, Corneal Implants, Glaucoma Implants, Ocular Prosthesis), By Application (Glaucoma, Drug Delivery), By End-use (Hospitals, Ophthalmic Clinics, and Specialty Eye Institutes); By Region (U.S., Canada, Mexico, Rest of North America, UK, France, Germany, Italy, Spain, Benelux Union, Nordic Countries , Rest of Europe, China, Japan, India, South Korea, Singapore, Philippines, Indonesia, Thailand, Malaysia, Vietnam, Rest of Southeast Asia, Brazil, Argentina Rest of Latin America, Saudi Arabia, UAE, Egypt, Kuwait, GCC countries, Southern Africa, Rest of Middle East & Africa) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
Industry Trends
Global Ocular Implants Market was valued at US$ 1,043.21 million in 2018 and is expected to reach US$ 1,674.7 million by 2027, growing at an estimated CAGR of 5.4% over the forecast period.
An intraocular lens implant is an artificial substitute for eye lens. The intraocular lens (IOL) is an external aid that is surgically implanted in the living eye to restore vision sharpness, often after a cataract has been removed. For the individual patient, it must be clear, tolerable material of an appropriate size, form, and strength. It has to stay in place for better result. An ideal eye implant should be non-allergenic, non-toxic, not triggering an immune response in the host tissue, mechanically stable with satisfactory motility. Most surgeons add extrinsic muscles to the ocular implant even reducing the risk of exposure or extrusion for improved motility of eye prosthesis. This is why they are addressing forms of integrated and non-integrated implants. A significant Ocular Implants Market trend in the latest eye implants is the increase in preference for customized ocular prostheses. For patients with facial disfigurement owing to shrunken eyelids induced by eye tissue harm, a custom-made prosthesis is suggested. Its advantages include improved aesthetics, precise sclera contour, and precise placement, among others, resulting in wide-ranging patient acceptance.
Ocular implants are described as artificial surgically implanted instruments used after enucleation, evisceration, or orbital exenteration to restore the sharpness of vision. The size, shape, and strength of eye implants depend on the patient. Different non-integrated and incorporated materials are used for ocular implants, including hydroxyapatite, Medpor, and bio-ceramic. Porous embedded implants (hydroxyapatite) may indicate certain hazards and problems, such as extrusion, dehiscence, or diseases. Currently, biomaterials with nanostructure deliver a greater rate of healing and proliferation at economical prices and fewer complications after surgery. Ocular implants also have applications to treat ophthalmological illnesses ranging from glaucoma to diabetic retinopathy in targeted and sustained drug delivery.
Growing product launches for various types of eye implants that are widely used in ophthalmic surgery to correct ophthalmic deformities are expected to drive global ocular implants market growth for eye implants. For example, in February 2019, EyePoint Pharmaceuticals, Inc. launched its YUTIQ in the U.S. YUTIQ is a three-year intravitreal micro-insert for chronic non-infectious uveitis treatment affecting the posterior segment of the eye. The product was approved by the U.S. FDA in October 2018.
Moreover, an increasing number of research and development activities to develop innovative ocular implant is contributing to the growth of global ocular implant market. For example, in July 2018, Genentech, Inc. announced positive results for a Phase II clinical trial conducted to assess the safety and efficacy of the investigational Port Delivery System (PDS) with Ranibizumab, the first-ever eye implant to achieve sustained delivery of a biological medicine, in people with wet age-related macular degeneration (AMD). Furthermore, the rising number of clinical studies to develop innovative ocular implants to be used in the treatment of ocular disorder such as glaucoma and corneal disease is expected to drive the growth of the global ocular implant market. For instance, in July 2018, PolyActiva Pty Ltd initiated a phase 1 clinical trial to determine and evaluate the safety, tolerability, and biodegradation of a prostaglandin (PA5108) ocular implant for treatment of open-angle glaucoma. The study are estimated to complete in September 2019.
The availability of assistive financial assistance and an increase in the occurrence of recorded visual impairments are expected to fuel competition, encouraging new entrants to enter market space. The players follow various strategies such as alliances and partnerships with other players in the Healthcare industry to improve their market share. STAAR Surgical Company, for example, announced a cooperative agreement with the World Eye Hospital Group. This strategic cooperation empowered the company to become the largest refractive eye surgery treatment solutions provider in South East Europe, and it is anticipated to help the company tap into lucrative opportunities in the region over the forecast period.
Some studies have found that integrated porous implants (hydroxyapatite) could have complications such as extrusion, dehiscence, or infections. For enucleated patients, the use of an integrated HA (Hydroxyapatite) implant is preferred, which allows for better integration of the ocular prosthesis resulting in good motility. Developing the concept of nanostructured biomaterial is of great interest in its ability to meet the need for an "ideal" eye implant with a higher rate of healing and proliferation, low post-op complications (short / long-term) and affordable cost.
Market Trends, By Product
The product-based industry is bifurcated: intraocular lenses, corneal implants, orbital implants, glaucoma implants, and ocular prosthesis. The category of glaucoma implants had the largest market share in 2018, due to the increased occurrence of glaucoma across the world. In 2016, about 3.0 million people in America suffered from Glaucoma, according to data published by the Glaucoma Research Foundation. Glaucoma is one of the leading causes of blindness worldwide. A high incidence of glaucoma around the world has driven manufacturers to focus on developing and selling minimally invasive products for glaucoma treatment. The development of non-invasive surgical devices such as iStent, and gel micro stent (XEN), for example, has catered for the high growth of minimally invasive glaucoma surgical devices. Glaucoma is caused by the damage to the optic nerve, and may potentially lead to loss of vision if not treated correctly. It is normal in the geriatric community, and open-angle glaucoma is the most commonly occurring form of glaucoma. With the rising occurrence of glaucoma, demand for glaucoma implants is expected to rise, thereby fuelling the ocular implants market. Growing awareness of this disease also helps in increasing the demand for early treatment. And its predominance is expected to continue over the forecast period. The most rapidly growing segment is expected to be the intraocular lenses. Because of their prolonged use in presbyopia, nearsightedness, and farsightedness, intraocular lenses have gained popularity. Therefore, these segments are expected to show lucrative growth over the forecast period.
Market Trends, By End User
The global ocular implants market is segmented into hospitals, ophthalmic clinics, and specialty eye institutes supported end-use. As a result of the increasing frequency of treatment for vision impairment in hospitals, the hospital segment is that the largest segment, while specialist eye institutes are projected to be the fastest-growing market segment thanks to the increased need for eye care services in remote areas. In 2018, the U.S government offered 44.0% of its designated assets for Research and development concerning welfare to the eye inspect establishments, as expressed by the National Science Establishment. Thus, thanks to the ascent in various clinical preliminaries concerning intraocular focal points and expansion in government consumption for Research and development, this fragment is foreseen to witness rewarding development.
Market Trends, By Region
Based on the region, the ocular implants market is bifurcated into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.North America dominated the global ocular implant market and is expected to maintain its place. Increased population aging and accessibility of reimbursement facilities are boosting regional market growth. The market for eye implants in Asia Pacific is expected to experience the highest growth rate due to an increase in the diabetic population along with an increase in government spending on healthcare. Developing nations such as China and Japan are anticipated to be the fastest growing countries in Asia Pacific due to the increasing amount of reported instances of blindness, reducing cataract surgery, and increasing individual and government expenditure on eye care.
Ocular Implants Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of ocular implants market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Bausch & Lomb, Alcon, Carl Zeiss, Johnson & Johnson, MORCHER GmbH, and STAAR surgical are some of the main players in the ocular implants market. It is expected that the availability of economic assistance and the increased incidence of recorded visual impairments will fuel competition and thus encourage new entrants to enter market space. The global market for ocular implants is extremely fragmented with several local and foreign players on the market providing various implantable products. In the ocular implants industry, players or service suppliers are coming up with a tailored solution that addresses patient needs. Players on the market for are creating new models that are affected by viscoelastic technology and others to obtain greater market share in the market for ocular implants.
Ocular Implants Market:
- By Product
- Intraocular Lenses
- Corneal Implants
- Glaucoma Implants
- Ocular Prosthesis
- By Application
- Glaucoma
- Drug Delivery
- By End User
- Hospitals
- Ophthalmic Clinics
- Specialty Eye Institutes
- By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Ocular Implants Market
6. Market Synopsis:
Ocular Implants Market
7. Ocular Implants Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Ocular Implants Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Ocular Implants Market
7.6. Porter’s
Five Force Analysis
8. Global Ocular Implants Market Analysis and Forecasts, 2019 –
2027
8.1. Overview
8.1.1. Global
Ocular Implants Market Revenue (US$ Mn)
8.2. Global
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
8.2.1. Intraocular
Lenses
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2018
8.2.1.3. Market
Forecast, 2019 – 2027
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2018
8.2.1.5.1.2. Market
Forecast, 2019 – 2027
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2018
8.2.1.5.2.2. Market
Forecast, 2019 – 2027
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2018
8.2.1.5.3.2. Market
Forecast, 2019 – 2027
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2018
8.2.1.5.4.2. Market
Forecast, 2019 – 2027
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2018
8.2.1.5.5.2. Market
Forecast, 2019 – 2027
8.2.2. Corneal
Implants
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 – 2018
8.2.2.3. Market
Forecast, 2019 – 2027
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 – 2018
8.2.2.5.1.2. Market
Forecast, 2019 – 2027
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2018
8.2.2.5.2.2. Market
Forecast, 2019 – 2027
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2018
8.2.2.5.3.2. Market
Forecast, 2019 – 2027
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2018
8.2.2.5.4.2. Market
Forecast, 2019 – 2027
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 – 2018
8.2.2.5.5.2. Market
Forecast, 2019 – 2027
8.2.3. Glaucoma
Implants
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 – 2018
8.2.3.3. Market
Forecast, 2019 – 2027
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 – 2018
8.2.3.5.1.2. Market
Forecast, 2019 – 2027
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2018
8.2.3.5.2.2. Market
Forecast, 2019 – 2027
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2018
8.2.3.5.3.2. Market
Forecast, 2019 – 2027
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2018
8.2.3.5.4.2. Market
Forecast, 2019 – 2027
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 – 2018
8.2.3.5.5.2. Market
Forecast, 2019 – 2027
8.2.4. Ocular
Prosthesis
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 – 2018
8.2.4.3. Market
Forecast, 2019 – 2027
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market
Estimation, 2015 – 2018
8.2.4.5.1.2. Market
Forecast, 2019 – 2027
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 – 2018
8.2.4.5.2.2. Market
Forecast, 2019 – 2027
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market
Estimation, 2015 – 2018
8.2.4.5.3.2. Market
Forecast, 2019 – 2027
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 – 2018
8.2.4.5.4.2. Market
Forecast, 2019 – 2027
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market
Estimation, 2015 – 2018
8.2.4.5.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Product
9. Global Ocular Implants Market Analysis and Forecasts, 2019 –
2027
9.1. Overview
9.2. Global
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Glaucoma
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2018
9.2.1.3. Market
Forecast, 2019 – 2027
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2018
9.2.1.5.1.2. Market
Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2018
9.2.1.5.2.2. Market
Forecast, 2019 – 2027
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2018
9.2.1.5.3.2. Market
Forecast, 2019 – 2027
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2018
9.2.1.5.4.2. Market
Forecast, 2019 – 2027
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2018
9.2.1.5.5.2. Market
Forecast, 2019 – 2027
9.2.2. Drug
Delivery
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2018
9.2.2.3. Market
Forecast, 2019 – 2027
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2018
9.2.2.5.1.2. Market
Forecast, 2019 – 2027
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2018
9.2.2.5.2.2. Market
Forecast, 2019 – 2027
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2018
9.2.2.5.3.2. Market
Forecast, 2019 – 2027
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2018
9.2.2.5.4.2. Market
Forecast, 2019 – 2027
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2018
9.2.2.5.5.2. Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By
Application
10. Global Ocular Implants Market Analysis and Forecasts, 2019 –
2027
10.1. Overview
10.2. Global
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
10.2.1. Hospitals
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 – 2018
10.2.1.3. Market
Forecast, 2019 – 2027
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 – 2018
10.2.1.5.1.2. Market
Forecast, 2019 – 2027
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2018
10.2.1.5.2.2. Market
Forecast, 2019 – 2027
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2018
10.2.1.5.3.2. Market
Forecast, 2019 – 2027
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2018
10.2.1.5.4.2. Market
Forecast, 2019 – 2027
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 – 2018
10.2.1.5.5.2. Market
Forecast, 2019 – 2027
10.2.2. Ophthalmic
Clinics
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 – 2018
10.2.2.3. Market
Forecast, 2019 – 2027
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 – 2018
10.2.2.5.1.2. Market
Forecast, 2019 – 2027
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2018
10.2.2.5.2.2. Market
Forecast, 2019 – 2027
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2018
10.2.2.5.3.2. Market
Forecast, 2019 – 2027
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2018
10.2.2.5.4.2. Market
Forecast, 2019 – 2027
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 – 2018
10.2.2.5.5.2. Market
Forecast, 2019 – 2027
10.2.3. Specialty
Eye Institutes
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 – 2018
10.2.3.3. Market
Forecast, 2019 – 2027
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 – 2018
10.2.3.5.1.2. Market
Forecast, 2019 – 2027
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 – 2018
10.2.3.5.2.2. Market
Forecast, 2019 – 2027
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 – 2018
10.2.3.5.3.2. Market
Forecast, 2019 – 2027
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 – 2018
10.2.3.5.4.2. Market
Forecast, 2019 – 2027
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 – 2018
10.2.3.5.5.2. Market
Forecast, 2019 – 2027
10.3. Key
Segment for Channeling Investments
10.3.1. By End
User
11. North America Ocular Implants Market Analysis and Forecasts,
2019 - 2027
11.1. Overview
11.1.1. North
America Ocular Implants Market Revenue (US$ Mn)
11.2. North
America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
11.2.1. Intraocular
Lenses
11.2.2. Corneal
Implants
11.2.3. Glaucoma
Implants
11.2.4. Ocular
Prosthesis
11.3. North
America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
11.3.1. Glaucoma
11.3.2. Drug
Delivery
11.4. North
America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
11.4.1. Hospitals
11.4.2. Ophthalmic
Clinics
11.4.3. Specialty
Eye Institutes
11.5. North
America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
11.5.1.1.1. Intraocular
Lenses
11.5.1.1.2. Corneal
Implants
11.5.1.1.3. Glaucoma
Implants
11.5.1.1.4. Ocular
Prosthesis
11.5.1.2. U.S
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
11.5.1.2.1. Glaucoma
11.5.1.2.2. Drug
Delivery
11.5.1.3. U.S
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
11.5.1.3.1. Hospitals
11.5.1.3.2. Ophthalmic
Clinics
11.5.1.3.3. Specialty
Eye Institutes
11.5.2. Canada
11.5.2.1. Canada
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
11.5.2.1.1. Intraocular
Lenses
11.5.2.1.2. Corneal
Implants
11.5.2.1.3. Glaucoma
Implants
11.5.2.1.4. Ocular
Prosthesis
11.5.2.2. Canada
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
11.5.2.2.1. Glaucoma
11.5.2.2.2. Drug
Delivery
11.5.2.3. Canada
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
11.5.2.3.1. Hospitals
11.5.2.3.2. Ophthalmic
Clinics
11.5.2.3.3. Specialty
Eye Institutes
11.5.3. Mexico
11.5.3.1. Mexico
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
11.5.3.1.1. Intraocular
Lenses
11.5.3.1.2. Corneal
Implants
11.5.3.1.3. Glaucoma
Implants
11.5.3.1.4. Ocular
Prosthesis
11.5.3.2. Mexico
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
11.5.3.2.1. Glaucoma
11.5.3.2.2. Drug
Delivery
11.5.3.3. Mexico
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
11.5.3.3.1. Hospitals
11.5.3.3.2. Ophthalmic
Clinics
11.5.3.3.3. Specialty
Eye Institutes
11.5.4. Rest of
North America
11.5.4.1. Rest
of North America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By
Product
11.5.4.1.1. Intraocular
Lenses
11.5.4.1.2. Corneal
Implants
11.5.4.1.3. Glaucoma
Implants
11.5.4.1.4. Ocular
Prosthesis
11.5.4.2. Rest
of North America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By
Application
11.5.4.2.1. Glaucoma
11.5.4.2.2. Drug
Delivery
11.5.4.3. Rest
of North America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End
User
11.5.4.3.1. Hospitals
11.5.4.3.2. Ophthalmic
Clinics
11.5.4.3.3. Specialty
Eye Institutes
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Product
11.6.3. By
Application
11.6.4. By End
User
12. Europe Ocular Implants Market Analysis and Forecasts, 2019 -
2027
12.1. Overview
12.1.1. Europe
Ocular Implants Market Revenue (US$ Mn)
12.2. Europe
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
12.2.1. Intraocular
Lenses
12.2.2. Corneal
Implants
12.2.3. Glaucoma
Implants
12.2.4. Ocular
Prosthesis
12.3. Europe
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.3.1. Glaucoma
12.3.2. Drug
Delivery
12.4. Europe
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
12.4.1. Hospitals
12.4.2. Ophthalmic
Clinics
12.4.3. Specialty
Eye Institutes
12.5. Europe
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
12.5.1.1.1. Intraocular
Lenses
12.5.1.1.2. Corneal
Implants
12.5.1.1.3. Glaucoma
Implants
12.5.1.1.4. Ocular
Prosthesis
12.5.1.2. France
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.5.1.2.1. Glaucoma
12.5.1.2.2. Drug
Delivery
12.5.1.3. France
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
12.5.1.3.1. Hospitals
12.5.1.3.2. Ophthalmic
Clinics
12.5.1.3.3. Specialty
Eye Institutes
12.5.2. The UK
12.5.2.1. The
UK Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
12.5.2.1.1. Intraocular
Lenses
12.5.2.1.2. Corneal
Implants
12.5.2.1.3. Glaucoma
Implants
12.5.2.1.4. Ocular
Prosthesis
12.5.2.2. The
UK Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.5.2.2.1. Glaucoma
12.5.2.2.2. Drug
Delivery
12.5.2.3. The
UK Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
12.5.2.3.1. Hospitals
12.5.2.3.2. Ophthalmic
Clinics
12.5.2.3.3. Specialty
Eye Institutes
12.5.3. Spain
12.5.3.1. Spain
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
12.5.3.1.1. Intraocular
Lenses
12.5.3.1.2. Corneal
Implants
12.5.3.1.3. Glaucoma
Implants
12.5.3.1.4. Ocular
Prosthesis
12.5.3.2. Spain
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.5.3.2.1. Glaucoma
12.5.3.2.2. Drug
Delivery
12.5.3.3. Spain
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
12.5.3.3.1. Hospitals
12.5.3.3.2. Ophthalmic
Clinics
12.5.3.3.3. Specialty
Eye Institutes
12.5.4. Germany
12.5.4.1. Germany
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
12.5.4.1.1. Intraocular
Lenses
12.5.4.1.2. Corneal
Implants
12.5.4.1.3. Glaucoma
Implants
12.5.4.1.4. Ocular
Prosthesis
12.5.4.2. Germany
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.5.4.2.1. Glaucoma
12.5.4.2.2. Drug
Delivery
12.5.4.3. Germany
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
12.5.4.3.1. Hospitals
12.5.4.3.2. Ophthalmic
Clinics
12.5.4.3.3. Specialty
Eye Institutes
12.5.5. Italy
12.5.5.1. Italy
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
12.5.5.1.1. Intraocular
Lenses
12.5.5.1.2. Corneal
Implants
12.5.5.1.3. Glaucoma
Implants
12.5.5.1.4. Ocular
Prosthesis
12.5.5.2. Italy
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.5.5.2.1. Glaucoma
12.5.5.2.2. Drug
Delivery
12.5.5.3. Italy
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
12.5.5.3.1. Hospitals
12.5.5.3.2. Ophthalmic
Clinics
12.5.5.3.3. Specialty
Eye Institutes
12.5.6. Nordic
Countries
12.5.6.1. Nordic
Countries Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
12.5.6.1.1. Intraocular
Lenses
12.5.6.1.2. Corneal
Implants
12.5.6.1.3. Glaucoma
Implants
12.5.6.1.4. Ocular
Prosthesis
12.5.6.2. Nordic
Countries Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.5.6.2.1. Glaucoma
12.5.6.2.2. Drug
Delivery
12.5.6.3. Nordic
Countries Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
12.5.6.3.1. Hospitals
12.5.6.3.2. Ophthalmic
Clinics
12.5.6.3.3. Specialty
Eye Institutes
12.5.6.4. Nordic
Countries Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux
Union Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
12.5.7.1.1. Intraocular
Lenses
12.5.7.1.2. Corneal
Implants
12.5.7.1.3. Glaucoma
Implants
12.5.7.1.4. Ocular
Prosthesis
12.5.7.2. Benelux
Union Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.5.7.2.1. Glaucoma
12.5.7.2.2. Drug
Delivery
12.5.7.3. Benelux
Union Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
12.5.7.3.1. Hospitals
12.5.7.3.2. Ophthalmic
Clinics
12.5.7.3.3. Specialty
Eye Institutes
12.5.7.4. Benelux
Union Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The
Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest
of Europe Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
12.5.8.1.1. Intraocular
Lenses
12.5.8.1.2. Corneal
Implants
12.5.8.1.3. Glaucoma
Implants
12.5.8.1.4. Ocular
Prosthesis
12.5.8.2. Rest
of Europe Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.5.8.2.1. Glaucoma
12.5.8.2.2. Drug
Delivery
12.5.8.3. Rest
of Europe Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
12.5.8.3.1. Hospitals
12.5.8.3.2. Ophthalmic
Clinics
12.5.8.3.3. Specialty
Eye Institutes
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By
Product
12.6.3. By
Application
12.6.4. By End
User
13. Asia Pacific Ocular Implants Market Analysis and Forecasts,
2019 - 2027
13.1. Overview
13.1.1. Asia
Pacific Ocular Implants Market Revenue (US$ Mn)
13.2. Asia
Pacific Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
13.2.1. Intraocular
Lenses
13.2.2. Corneal
Implants
13.2.3. Glaucoma
Implants
13.2.4. Ocular
Prosthesis
13.3. Asia
Pacific Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.3.1. Glaucoma
13.3.2. Drug
Delivery
13.4. Asia
Pacific Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
13.4.1. Hospitals
13.4.2. Ophthalmic
Clinics
13.4.3. Specialty
Eye Institutes
13.5. Asia
Pacific Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
13.5.1.1.1. Intraocular
Lenses
13.5.1.1.2. Corneal
Implants
13.5.1.1.3. Glaucoma
Implants
13.5.1.1.4. Ocular
Prosthesis
13.5.1.2. China
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1.2.1. Glaucoma
13.5.1.2.2. Drug
Delivery
13.5.1.3. China
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
13.5.1.3.1. Hospitals
13.5.1.3.2. Ophthalmic
Clinics
13.5.1.3.3. Specialty
Eye Institutes
13.5.2. Japan
13.5.2.1. Japan
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
13.5.2.1.1. Intraocular
Lenses
13.5.2.1.2. Corneal
Implants
13.5.2.1.3. Glaucoma
Implants
13.5.2.1.4. Ocular
Prosthesis
13.5.2.2. Japan
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.5.2.2.1. Glaucoma
13.5.2.2.2. Drug
Delivery
13.5.2.3. Japan
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
13.5.2.3.1. Hospitals
13.5.2.3.2. Ophthalmic
Clinics
13.5.2.3.3. Specialty
Eye Institutes
13.5.3. India
13.5.3.1. India
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
13.5.3.1.1. Intraocular
Lenses
13.5.3.1.2. Corneal
Implants
13.5.3.1.3. Glaucoma
Implants
13.5.3.1.4. Ocular
Prosthesis
13.5.3.2. India
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.5.3.2.1. Glaucoma
13.5.3.2.2. Drug
Delivery
13.5.3.3. India
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
13.5.3.3.1. Hospitals
13.5.3.3.2. Ophthalmic
Clinics
13.5.3.3.3. Specialty
Eye Institutes
13.5.4. New
Zealand
13.5.4.1. New
Zealand Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
13.5.4.1.1. Intraocular
Lenses
13.5.4.1.2. Corneal
Implants
13.5.4.1.3. Glaucoma
Implants
13.5.4.1.4. Ocular
Prosthesis
13.5.4.2. New
Zealand Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.5.4.2.1. Glaucoma
13.5.4.2.2. Drug
Delivery
13.5.4.3. New
Zealand Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
13.5.4.3.1. Hospitals
13.5.4.3.2. Ophthalmic
Clinics
13.5.4.3.3. Specialty
Eye Institutes
13.5.5. Australia
13.5.5.1. Australia
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
13.5.5.1.1. Intraocular
Lenses
13.5.5.1.2. Corneal
Implants
13.5.5.1.3. Glaucoma
Implants
13.5.5.1.4. Ocular
Prosthesis
13.5.5.2. Australia
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.5.5.2.1. Glaucoma
13.5.5.2.2. Drug
Delivery
13.5.5.3. Australia
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
13.5.5.3.1. Hospitals
13.5.5.3.2. Ophthalmic
Clinics
13.5.5.3.3. Specialty
Eye Institutes
13.5.6. South
Korea
13.5.6.1. South
Korea Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
13.5.6.1.1. Intraocular
Lenses
13.5.6.1.2. Corneal
Implants
13.5.6.1.3. Glaucoma
Implants
13.5.6.1.4. Ocular
Prosthesis
13.5.6.2. South
Korea Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.5.6.2.1. Glaucoma
13.5.6.2.2. Drug
Delivery
13.5.6.3. South
Korea Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
13.5.6.3.1. Hospitals
13.5.6.3.2. Ophthalmic
Clinics
13.5.6.3.3. Specialty
Eye Institutes
13.5.7. Southeast
Asia
13.5.7.1. Southeast
Asia Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
13.5.7.1.1. Intraocular
Lenses
13.5.7.1.2. Corneal
Implants
13.5.7.1.3. Glaucoma
Implants
13.5.7.1.4. Ocular
Prosthesis
13.5.7.2. Southeast
Asia Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.5.7.2.1. Glaucoma
13.5.7.2.2. Drug
Delivery
13.5.7.3. Southeast
Asia Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
13.5.7.3.1. Hospitals
13.5.7.3.2. Ophthalmic
Clinics
13.5.7.3.3. Specialty
Eye Institutes
13.5.7.4. Southeast
Asia Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest
of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest
of Asia Pacific Ocular Implants Market Revenue (US$ Mn) and Forecasts, By
Product
13.5.8.1.1. Intraocular
Lenses
13.5.8.1.2. Corneal
Implants
13.5.8.1.3. Glaucoma
Implants
13.5.8.1.4. Ocular
Prosthesis
13.5.8.2. Rest
of Asia Pacific Ocular Implants Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.8.2.1. Glaucoma
13.5.8.2.2. Drug
Delivery
13.5.8.3. Rest
of Asia Pacific Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End
User
13.5.8.3.1. Hospitals
13.5.8.3.2. Ophthalmic
Clinics
13.5.8.3.3. Specialty
Eye Institutes
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Product
13.6.3. By
Application
13.6.4. By End
User
14. Middle East and Africa Ocular Implants Market Analysis and
Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Middle
East and Africa Ocular Implants Market Revenue (US$ Mn)
14.2. Middle
East and Africa Ocular Implants Market Revenue (US$ Mn) and Forecasts, By
Product
14.2.1. Intraocular
Lenses
14.2.2. Corneal
Implants
14.2.3. Glaucoma
Implants
14.2.4. Ocular
Prosthesis
14.3. Middle
East and Africa Ocular Implants Market Revenue (US$ Mn) and Forecasts, By
Application
14.3.1. Glaucoma
14.3.2. Drug
Delivery
14.4. Middle
East and Africa Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End
User
14.4.1. Hospitals
14.4.2. Ophthalmic
Clinics
14.4.3. Specialty
Eye Institutes
14.5. Middle
East and Africa Ocular Implants Market Revenue (US$ Mn) and Forecasts, By
Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi
Arabia Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
14.5.1.1.1. Intraocular
Lenses
14.5.1.1.2. Corneal
Implants
14.5.1.1.3. Glaucoma
Implants
14.5.1.1.4. Ocular
Prosthesis
14.5.1.2. Saudi
Arabia Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.5.1.2.1. Glaucoma
14.5.1.2.2. Drug
Delivery
14.5.1.3. Saudi
Arabia Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
14.5.1.3.1. Hospitals
14.5.1.3.2. Ophthalmic
Clinics
14.5.1.3.3. Specialty
Eye Institutes
14.5.2. UAE
14.5.2.1. UAE
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
14.5.2.1.1. Intraocular
Lenses
14.5.2.1.2. Corneal
Implants
14.5.2.1.3. Glaucoma
Implants
14.5.2.1.4. Ocular
Prosthesis
14.5.2.2. UAE
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.5.2.2.1. Glaucoma
14.5.2.2.2. Drug
Delivery
14.5.2.3. UAE
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
14.5.2.3.1. Hospitals
14.5.2.3.2. Ophthalmic
Clinics
14.5.2.3.3. Specialty
Eye Institutes
14.5.3. Egypt
14.5.3.1. Egypt
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
14.5.3.1.1. Intraocular
Lenses
14.5.3.1.2. Corneal
Implants
14.5.3.1.3. Glaucoma
Implants
14.5.3.1.4. Ocular
Prosthesis
14.5.3.2. Egypt
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.5.3.2.1. Glaucoma
14.5.3.2.2. Drug
Delivery
14.5.3.3. Egypt
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
14.5.3.3.1. Hospitals
14.5.3.3.2. Ophthalmic
Clinics
14.5.3.3.3. Specialty
Eye Institutes
14.5.4. Kuwait
14.5.4.1. Kuwait
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
14.5.4.1.1. Intraocular
Lenses
14.5.4.1.2. Corneal
Implants
14.5.4.1.3. Glaucoma
Implants
14.5.4.1.4. Ocular
Prosthesis
14.5.4.2. Kuwait
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.5.4.2.1. Glaucoma
14.5.4.2.2. Drug
Delivery
14.5.4.3. Kuwait
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
14.5.4.3.1. Hospitals
14.5.4.3.2. Ophthalmic
Clinics
14.5.4.3.3. Specialty
Eye Institutes
14.5.5. South
Africa
14.5.5.1. South
Africa Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
14.5.5.1.1. Intraocular
Lenses
14.5.5.1.2. Corneal
Implants
14.5.5.1.3. Glaucoma
Implants
14.5.5.1.4. Ocular
Prosthesis
14.5.5.2. South
Africa Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.5.5.2.1. Glaucoma
14.5.5.2.2. Drug
Delivery
14.5.5.3. South
Africa Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
14.5.5.3.1. Hospitals
14.5.5.3.2. Ophthalmic
Clinics
14.5.5.3.3. Specialty
Eye Institutes
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest
of Middle East & Africa Ocular Implants Market Revenue (US$ Mn) and
Forecasts, By Product
14.5.6.1.1. Intraocular
Lenses
14.5.6.1.2. Corneal
Implants
14.5.6.1.3. Glaucoma
Implants
14.5.6.1.4. Ocular
Prosthesis
14.5.6.2. Rest
of Middle East & Africa Ocular Implants Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.6.2.1. Glaucoma
14.5.6.2.2. Drug
Delivery
14.5.6.3. Rest
of Middle East & Africa Ocular Implants Market Revenue (US$ Mn) and
Forecasts, By End User
14.5.6.3.1. Hospitals
14.5.6.3.2. Ophthalmic
Clinics
14.5.6.3.3. Specialty
Eye Institutes
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Product
14.6.3. By
Application
14.6.4. By End
User
15. Latin America Ocular Implants Market Analysis and Forecasts,
2019 - 2027
15.1. Overview
15.1.1. Latin
America Ocular Implants Market Revenue (US$ Mn)
15.2. Latin
America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
15.2.1. Intraocular
Lenses
15.2.2. Corneal
Implants
15.2.3. Glaucoma
Implants
15.2.4. Ocular
Prosthesis
15.3. Latin
America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
15.3.1. Glaucoma
15.3.2. Drug
Delivery
15.4. Latin
America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
15.4.1. Hospitals
15.4.2. Ophthalmic
Clinics
15.4.3. Specialty
Eye Institutes
15.5. Latin
America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
15.5.1.1.1. Intraocular
Lenses
15.5.1.1.2. Corneal
Implants
15.5.1.1.3. Glaucoma
Implants
15.5.1.1.4. Ocular
Prosthesis
15.5.1.2. Brazil
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
15.5.1.2.1. Glaucoma
15.5.1.2.2. Drug
Delivery
15.5.1.3. Brazil
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
15.5.1.3.1. Hospitals
15.5.1.3.2. Ophthalmic
Clinics
15.5.1.3.3. Specialty
Eye Institutes
15.5.2. Argentina
15.5.2.1. Argentina
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Product
15.5.2.1.1. Intraocular
Lenses
15.5.2.1.2. Corneal
Implants
15.5.2.1.3. Glaucoma
Implants
15.5.2.1.4. Ocular
Prosthesis
15.5.2.2. Argentina
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By Application
15.5.2.2.1. Glaucoma
15.5.2.2.2. Drug
Delivery
15.5.2.3. Argentina
Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End User
15.5.2.3.1. Hospitals
15.5.2.3.2. Ophthalmic
Clinics
15.5.2.3.3. Specialty
Eye Institutes
15.5.3. Rest of
Latin America
15.5.3.1. Rest
of Latin America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By
Product
15.5.3.1.1. Intraocular
Lenses
15.5.3.1.2. Corneal
Implants
15.5.3.1.3. Glaucoma
Implants
15.5.3.1.4. Ocular
Prosthesis
15.5.3.2. Rest
of Latin America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By
Application
15.5.3.2.1. Glaucoma
15.5.3.2.2. Drug
Delivery
15.5.3.3. Rest
of Latin America Ocular Implants Market Revenue (US$ Mn) and Forecasts, By End
User
15.5.3.3.1. Hospitals
15.5.3.3.2. Ophthalmic
Clinics
15.5.3.3.3. Specialty
Eye Institutes
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Product
15.6.3. By
Application
15.6.4. By End
User
16. Competitive Benchmarking
16.1. Market
Share Analysis, 2018
16.2. Global
Presence and Growth Strategies
16.2.1. Mergers
and Acquisitions
16.2.2. Product
Launches
16.2.3. Investments
Trends
16.2.4. R&D
Initiatives
17. Player Profiles
17.1. STAAR
SURGICAL
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. Alcon
Vision LLC
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business
Strategies
17.3. Johnson
& Johnson Vision Care, Inc.
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business
Strategies
17.4. MORCHER
GmbH
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. Bausch
and Lomb Inc.
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. Carl
Zeiss Meditec AG
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT Analysis
17.7. Other
Market Participants
18. Business
Strategies
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
